Chi-Mu Chuang

Medicine · Health Sciences

16h-index828citations24works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(8), Intraperitoneal and Appendiceal Malignancies(5), Immunotherapy and Immune Responses(4), Uterine Myomas and Treatments(4), Sarcoma Diagnosis and Treatment(3)

Publications24 total

Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers
Cancer Research·2020· 78 citedOpen Access
A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of 188Re-liposome in patients with metastatic tumors
EJNMMI Research·2019· 29 citedOpen Access
Evaluation of a Simple and Safe Tumor Drilling Technique to Potentiate the Effect of Intraperitoneal Chemotherapy in the Treatment of Recurrent Epithelial Ovarian, Tubal, and Peritoneal Cancer: A Matched Retrospective Cohort Study
Cancer Control·2019· 2 citedOpen Access
Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review
Journal of Ovarian Research·2018· 15 citedOpen Access
Neurofibroma involving obturator nerve mimicking an adnexal mass: a rare case report and PRISMA-driven systematic review
Journal of Ovarian Research·2018· 8 citedOpen Access
The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels
PLoS ONE·2017· 29 citedOpen Access
188Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept
International Journal of Molecular Sciences·2017· 46 citedOpen Access
Gene Set−Based Integrative Analysis Revealing Two Distinct Functional Regulation Patterns in Four Common Subtypes of Epithelial Ovarian Cancer
International Journal of Molecular Sciences·2016· 15 citedOpen Access
Uterine sarcoma Part II—Uterine endometrial stromal sarcoma: The TAG systematic review
Taiwanese Journal of Obstetrics and Gynecology·2016· 53 citedOpen Access
Uterine sarcoma Part I—Uterine leiomyosarcoma: The Topic Advisory Group systematic review
Taiwanese Journal of Obstetrics and Gynecology·2016· 45 citedOpen Access
Gene Set-Based Functionome Analysis of Pathogenesis in Epithelial Ovarian Serous Carcinoma and the Molecular Features in Different FIGO Stages
International Journal of Molecular Sciences·2016· 10 citedOpen Access
Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort study
Chinese Journal of Cancer·2016Open Access
Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
Oncotarget·2015· 85 citedOpen Access
Comparison of single-incision mini-slings (Ajust) and standard transobturator midurethral slings (Align) in the management of female stress urinary incontinence: A 1-year follow-up
Taiwanese Journal of Obstetrics and Gynecology·2015· 15 citedOpen Access
The risk of irritable bowel syndrome in patients with endometriosis during a 5-year follow-up: a nationwide population-based cohort study
International Journal of Colorectal Disease·2015· 28 cited
Intraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects metabolic reprogramming and effectively inhibits cancer stem cells in Taxol(®)-resistant ovarian cancer.
PubMed·2015· 27 citedOpen Access
Primary fallopian tube cancer: Domestic data and up-to-date review
Taiwanese Journal of Obstetrics and Gynecology·2014· 39 citedOpen Access
Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model
Drug Delivery and Translational Research·2014· 18 citedOpen Access
The Role of Secondary Cytoreductive Surgery in Patients with Recurrent Epithelial Ovarian, Tubal, and Peritoneal Cancers: A Comparative Effectiveness Analysis
The Oncologist·2012· 16 citedOpen Access
Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination
Journal of Biomedical Science·2010· 43 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Cheng‐Chang Chang(9), Peng‐Hui Wang(7), Hua-Hsi Wu(7), Chien‐Fu Hung(6), Kuan-Chong Chao(6), Yi‐Jen Chen(6), Archana Monie(5), Ming-Shyen Yen(5), Ming‐Shyen Yen(5), Annie A. Wu(4), Nae-Fang Twu(4), Huann-Cheng Horng(4), Yen-Hou Chang(4), Hsiang-Tai Chao(4), Chia‐Hao Liu(4), Wen‐Hsun Chang(4), Yi Chang(3), Hei-Yu Lau(3), Ben-Shian Huang(3), Hsu‐Dong Sun(3)